Kelly H. Donaldson

6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases

Edgar R. Wood, Lisa M. Shewchuk, Byron Ellis et al. · Proceedings of the National Academy of Sciences · 2008 · 110 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Biochemistry +13

Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors

Tara Rheault, Thomas R. Caferro, Scott H. Dickerson et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 83 citations · Full text

Medicinal Chemistry, Medicine, Pharmacotherapy +5

Synthesis and Evaluation of Potent and Selective β₃ Adrenergic Receptor Agonists Containing Acylsulfonamide, Sulfonylsulfonamide, and Sulfonylurea Carboxylic Acid Isosteres

David Uehling, Kelly H. Donaldson, David N. Deaton et al. · Journal of Medicinal Chemistry · 2001 · 62 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Selective Beta +12

Biarylaniline Phenethanolamines as Potent and Selective β₃Adrenergic Receptor Agonists

David Uehling, Barry G. Shearer, Kelly H. Donaldson et al. · Journal of Medicinal Chemistry · 2006 · 41 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmacological Study +14

Heteroaryl-linked 5-(1H-benzimidazol-1-yl)-2-thiophenecarboxamides: Potent inhibitors of polo-like kinase 1 (PLK1) with improved drug-like properties

Tara Rheault, Kelly H. Donaldson, Jennifer G. Badiang-Alberti et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 16 citations · Full text

Medicinal Chemistry, Drug Target, Medicine +11